![Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative](https://www.imi.europa.eu/sites/default/files/styles/newsroom_details/public/uploads/images/news-events/Newsroom/j%20and%20j%20by%20rafapress%20via%20shutterstock.jpg?itok=gZGJMJG9)
Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative
![Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-020-00243-x/MediaObjects/41541_2020_243_Fig2_HTML.png)
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines
![AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute](https://www.adventhealthresearchinstitute.com/sites/default/files/styles/crop_2_1/public/2020-11/GettyImages-1209679031_1.jpg?itok=xLetjBZf)
AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute
![Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic](https://www.frontiersin.org/files/Articles/566882/fphar-11-00937-HTML/image_m/fphar-11-00937-g001.jpg)
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
![J&J's Heaton becomes face of COVID-19 booster debate in first months as Janssen vaccine chief | Fierce Biotech J&J's Heaton becomes face of COVID-19 booster debate in first months as Janssen vaccine chief | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1637176632/Penny%20Heaton%20headshot.jpg/Penny%20Heaton%20headshot.jpg?VersionId=XT9dwEGI5jPJ2r2lC9ZqHDmIK.6LbXG7)
J&J's Heaton becomes face of COVID-19 booster debate in first months as Janssen vaccine chief | Fierce Biotech
![Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic](https://www.frontiersin.org/files/Articles/566882/fphar-11-00937-HTML/image_m/fphar-11-00937-g004.jpg)